NCT04840511 is a NA clinical trial of lidocaine group in Urologic Cancer, sponsored by The Catholic University of Korea.

Who is sponsoring NCT04840511?

NCT04840511 is sponsored by The Catholic University of Korea.

What drugs are being tested in NCT04840511?

Interventions in NCT04840511: lidocaine group, control group.

What condition does NCT04840511 study?

NCT04840511 studies Urologic Cancer.

Is NCT04840511 still recruiting?

NCT04840511 is currently active, enrolled. Last updated 13 January 2023.

Last reviewed 2023-01-13 · How we verify

NCT04840511

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping

Active, enrolled NA Last updated 13 January 2023

What this trial tests

NA trial testing lidocaine group in Urologic Cancer in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

27 September 2021

Primary endpoint
30 April 2022

30 April 2027

Quick facts

Lead sponsor	The Catholic University of Korea
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	60
Start date	27 September 2021
Primary completion	30 April 2022
Estimated completion	30 April 2027
Sites	1 location across South Korea

Drugs / interventions tested

lidocaine group
control group — full drug profile →

Conditions studied

Urologic Cancer — all drugs for Urologic Cancer →

Sponsor

The Catholic University of Korea

Who can join

Adults 20 to 75, male only, with Urologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be done to investigate perioperative lidocaine infusion on neutrophil extracellular trapping in the patients undergoing the robot-assisted prostatectomy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Harnessing myeloid cells in cancer.
Park SY, Pylaeva E, Bhuria V, Gambardella AR, et al · · 2025 · cited 15× · PMID 40050933 · DOI 10.1186/s12943-025-02249-2

Verify or expand the search:

Other trials of lidocaine group

Trials testing the same drug.

NCT06607861 — Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective · EARLY_PHASE1 · recruiting
NCT05541640 — Intraoperative Lidocaine Infusion and Surgery-induced Release of Pro-inflammatory Cytokines After Abdominal Surgery · NA · unknown

Other recruiting trials for Urologic Cancer

Currently open trials in the same condition.

NCT06397287 — PROM Project Urology · recruiting
NCT07416630 — Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients · NA · recruiting
NCT05899361 — A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest · NA · recruiting
NCT05725304 — The Registry of Genetic Expression of Taiwan Urologic Cancer · active not recruiting
NCT06357416 — The Man Van Project · NA · recruiting

Other The Catholic University of Korea trials

Trials by the same sponsor.

NCT06367998 — Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair · Phase 4 · not yet recruiting
NCT07174544 — Mobile Self-Management Program for Stress Reduction in Young Adults · NA · completed
NCT05671705 — Effect of Sarcopenia in Stroke Patients · completed
NCT05509244 — Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery · NA · unknown
NCT05539690 — Effect of Balance Training on White Matter Tracts in Healthy Elderly Population · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04840511 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Catholic University of Korea
Last refreshed: 13 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04840511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing